FDA, Novavax and influenza vaccine
A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% ...
FluMist is an efficacious and safely tolerated intranasal influenza vaccine. FluMist has gained approval from the FDA for ...
The project — in collaboration with Erasmus University in the Netherlands — is supported by a recent $7 million grant from ...
A large new study says the RSV vaccine is 80% effective at preventing hospitalization in older adults due to complications from the illness, and works just as well at protecting them from death or ...
By Melissa Patrick Kentucky Health News Even though the effectiveness of the influenza vaccine was lower in South America ...
The respiratory syncytial virus (RSV) vaccines were about 80% effective in older adults during the 2023-24 respiratory disease season, which was the first season after the shot was approved in the US, ...
An infant, and a 90+ year-old adult, were the first Connecticut residents to die from the flu in the 2024-25 season.
The Respiratory Surveillance Service has begun operating in Hungary as a first step in preparing for the flu season.